{"title":"干细胞诱导在活体肾移植的小型试验中成功","authors":"M. Hogan","doi":"10.1097/01.NEP.0000414763.04540.27","DOIUrl":null,"url":null,"abstract":"In recipients of a living-related donor kidney, induction therapy with autologous mesenchymal stem cells (MSCs) led to a lower rate of acute rejection and quicker recovery of renal function compared with anti-interleukin (IL)-2 receptor antibody, but the results are preliminary, experts interviewed for this article cautioned. The fi ndings were published in the Journal of the American Medical Association (2012;307:1169-1177). “This is the fi rst time such a study like this has been done,” said Jonathan Bromberg, MD, PhD, Chief of the Division of Transplantation and Professor of Surgery and of Microbiology and Immunology at the University of Maryland, when asked to comment on the fi ndings in a phone interview.","PeriodicalId":380758,"journal":{"name":"Nephrology Times","volume":"56 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2012-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Stem Cell Induction Successful in Small Trial of Living-Related Kidney Transplants\",\"authors\":\"M. Hogan\",\"doi\":\"10.1097/01.NEP.0000414763.04540.27\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"In recipients of a living-related donor kidney, induction therapy with autologous mesenchymal stem cells (MSCs) led to a lower rate of acute rejection and quicker recovery of renal function compared with anti-interleukin (IL)-2 receptor antibody, but the results are preliminary, experts interviewed for this article cautioned. The fi ndings were published in the Journal of the American Medical Association (2012;307:1169-1177). “This is the fi rst time such a study like this has been done,” said Jonathan Bromberg, MD, PhD, Chief of the Division of Transplantation and Professor of Surgery and of Microbiology and Immunology at the University of Maryland, when asked to comment on the fi ndings in a phone interview.\",\"PeriodicalId\":380758,\"journal\":{\"name\":\"Nephrology Times\",\"volume\":\"56 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2012-04-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Nephrology Times\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1097/01.NEP.0000414763.04540.27\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Nephrology Times","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1097/01.NEP.0000414763.04540.27","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Stem Cell Induction Successful in Small Trial of Living-Related Kidney Transplants
In recipients of a living-related donor kidney, induction therapy with autologous mesenchymal stem cells (MSCs) led to a lower rate of acute rejection and quicker recovery of renal function compared with anti-interleukin (IL)-2 receptor antibody, but the results are preliminary, experts interviewed for this article cautioned. The fi ndings were published in the Journal of the American Medical Association (2012;307:1169-1177). “This is the fi rst time such a study like this has been done,” said Jonathan Bromberg, MD, PhD, Chief of the Division of Transplantation and Professor of Surgery and of Microbiology and Immunology at the University of Maryland, when asked to comment on the fi ndings in a phone interview.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
